Apidra (insulin glulisine) / Sanofi 
Welcome,         Profile    Billing    Logout  
 42 Diseases   10 Trials   10 Trials   409 News 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Apidra (insulin glulisine) / Sanofi
ACTRN12616001158459: Comparison of the incidence and duration of hypoglycaemia assessed by Continuous Glucose Monitoring (CGM) in elderly type 2 Diabetes patients treated with two different insulin regimens (long and short acting insulin VS premixed insulin) .

Recruiting
4
84
 
Western Sydney Local Health District, Sanofi Australia
Type two Diabetes Mellitus, Hypoglycaemia in elderly type two Diabetes Mellitus patients on premixed insulin treatment
 
 
2005-005914-18: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro

Ongoing
4
30
Europe
Apidra, Humalog, Apidra, Humalog, Apidra, Humalog
Diabetes-Centre Quakenbrueck
Obese subjects with type 2 diabetes mellitus
 
 
2011-006179-20: Comparative randomized clinical trial between insulin analogues and human insulin in hospitalized patients treated with artificial tube feeding and who present high blood glucose levels. INSULINE study. Ensayo clínico aleatorizado comparativo entre análogos de insulina e insulina humana en pacientes hospitalizados tratados con alimentación artificial por sonda y que presentan niveles elevados de glucosa en sangre. Estudio INSULINE.

Ongoing
4
100
Europe
Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen, Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen
Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge., Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge.
Pacients receiving enteral nutrition and who present hyperglycemia. Pacientes tratados con nutrición enteral y que presenten hiperglicemia.
 
 
2014-002178-35: The renal effects of lixisenatide (a novel, gut-hormone based diabetes drug) and insulin glulisine (a common, wideley diabetes drug) Een onderzoek naar de werking van lixisenatide (een nieuw, op darmhormoon gebaseerd diabetes medicijn) en insuline glulisine (een veelgebruikt gangbaar diabetes medicijn) op de nierfunctie

Ongoing
4
40
Europe
Lixisenatide, Insulin glulisine, Lyxumia, Apidra, Lyxumia, Apidra
VU University Medical Center, VU University Medical Center, Sanofi-Aventis Netherlands B.V.
Type 2 Diabetes Mellitus Type 2 Diabetes
 
 
2017-000955-25: Investigation of efficacy, safety and usability of the GlucoTab system with an integrated long-acting insulin scheme for type 2 diabetes in the geriatric care setting Überprüfung der Wirksamkeit, Sicherheit und Benutzerfreundlichkeit des GlucoTab Systems mit einem intergrierten Schema eines langwirksamen Insulin für Typ 2 Diabetes in der Geriatrie

Ongoing
4
80
Europe
Solution for injection, Toujeo, Apidra
Medical University of Graz, FFG
Diabetes mellitus type 2 Diabetes mellitus Typ 2, Type 2 diabetes Typ 2 Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2013-004737-33: A prospective, multicenter, randomized, open-label study of 12 week duration to evaluate the effect of VILDagliptin added to insulin on glycaemic control in haemoDIALyzed patients with type 2 diabetes: probe analysis of CGM Etude prospective randomisée multicentrique d’évaluation de la VILDagliptine associée à l’insuline sur le contrôle glycémique chez les patients hémoDIALysés diabétiques de type 2 : étude VILDDIAL

Not yet recruiting
4
70
Europe
Vildagliptine, Tablet, Solution for injection, Suspension for injection, Galvus, LANTUS 100 unités/ml solution injectable, LANTUS 100 unités/ml solution injectable en cartouche, LANTUS 100 unités/ml solution injectable en cartouche pour OptiClik, Lantus OptiSet 100 unités/ml solution injectable en stylo prérempli, Lantus SoloStar 100 unités/ml solution injectable en stylo prérempli, Levemir 100 U/ml, solution injectable en cartouche, Levemir 100 U/ml, solution injectable en stylo prérempli, Levemir InnoLet 100 U/ml, solution injectable en stylo prérempli, Levemir FlexTouch 100 U/ml, solution injectable en stylo prérempli, Apidra 100 unités/ml solution injectable en flacon, Apidra 100 unités/ml solution injectable en cartouche, Apidra 100 unités/ml solution injectable en cartouche pour OptiClik, Apidra 100 unités/ml solution injectable en stylo prérempli, Apidra SoloStar 100 unités/ml solution injectable en stylo prérempli, Humalog 100 UI/ml, solution injectable en flacon, Humalog 100 UI/ml, solution injectable en cartouche, Humalog Mix25 100 UI/ml suspension injectable en flacon, Humalog Mix25 100 UI/ml suspension injectable en cartouche, Humalog Mix50 100 UI/ml suspension injectable en flacon, Humalog Mix50 100 UI/ml suspension injectable en cartouche, Humalog BASAL 100 UI/ml suspension injectable en cartouche, Humalog Pen 100 UI/ml, solution injectable, Humalog Mix25 100 UI/ml Pen, suspension injectable, Humalog Mix50 100 UI/ml Pen, suspension injectable, Humalog BASAL 100 UI/ml Pen, suspension injectable, Humalog 100 UI/ml KwikPen, solution injectable, Humalog Mix25 100 UI/ml KwikPen, suspension injectable, Humalog Mix50 100 UI/ml KwikPen, suspension injectable, Humalog BASAL 100 UI/ml KwikPen, suspension injectable, NovoRapid 100 U/ml, solution injectable, NovoRapid Penfill 100 U/ml, solution injectable en cartouche, NovoRapid FlexPen 100 U/ml, solution injectable en stylo prérempli, NovoRapid InnoLet 100 U/ml, solution injectable en stylo prérempli, NovoRapid FlexTouch 100 U/ml, solution injectable en stylo prérempli
Hôpitaux Universitaires de Strasbourg, HÔPITAUX UNIVERSITAIRES DE STRASBOURG, NOVARTIS PHARMASAS
haemodialyzed patients with type 2 diabetes patients hémodialysés et présentant un diabète de type 2, haemodialyzed patients with type 2 diabetes patients hémodialysés et présentant un diabète de type 2, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2018-000863-98: Investigation of acceptance, usability, safety and efficacy of the GlucoTab@MobileCare system for type 2 diabetes in domiciliary nursing care Überprüfung der Akzeptanz, Benutzerfreundlichkeit, Sicherheit und Wirksamkeit des GlucoTab@MobileCare Systems für Typ 2 Diabetes in der mobilen Hauskrankenpflege

Ongoing
4
10
Europe
Solution for injection, Toujeo, Apidra
Medical University of Graz, Zukunftfonds Steiermark
Diabetes mellitus type 2 Diabetes mellitus Typ 2, Type 2 Diabetes Typ 2 Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT04124302: The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

Not yet recruiting
4
70
NA
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
08/21
08/23
NCT04019821: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Completed
4
72
Europe
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
01/23
04/23
2010-022246-25: Diagnostic clinique et mécanismes physiopathologiques de l'allergie à l'insuline.

Not yet recruiting
3
70
Europe
Actrapid, Insulatard, Insuman Infusat, Humalog, NovoRapid, Apidra, Lantus, Levemir, Latex, Solution for injection, Suspension for injection, Solution for infusion, Actrapid, Insulatard, Novorapid, Levemir
Allergie à l'insuline
 
 
2016-001401-16: The SUGAR-DIP trial: Oral medication versus insulin for diabetes in pregnancy De SUGAR-DIP trial: Orale medicatie versus insuline voor zwangerschapsdiabetes

Ongoing
3
810
Europe
Metformin, Glibenclamide, Tablet, Injection, Metformin, Glibenclamide, Insulin: including - fast acting, analog: NovoRapid, Humalog, Apidra - short acting, human: Actrapid, Humuline Regular, Insuman Rapid - medium long acting, human: Insulatard, Humuline NPH, Insuman Basal - long acting analog: Lantus, Levemir
University Medical Center Utrecht, ZonMw
The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment. In deze trial wordt het ziektebeeld diabetes gravidarum onderzocht, waarbij er met dieetaanpassingen onvoldoende glucosecontrole is bereikt en er dus indicatie is voor aanvullende farmacologische behandeling., Gestational diabetes, also known as gestational diabetes mellitus, is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy. Zwangerschapssuikerziekte, ook wel zwangerschapsdiabetes, is een aandoening waarbij vrouwen waarbij niet al eerder suikerziekte is vastgesteld, tijdens de zwangerschap hoge bloedsuikerwaardes hebben., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
INHALE-1, NCT04974528: Afrezza® Study in Pediatrics

Active, not recruiting
3
319
US
Afrezza, Technosphere Insulin, Rapid-acting Insulin Analog, insulin aspart, insulin lispro, insulin glulisine, Novolog®, Fiasp®, Humalog®, Admelog®, Apidra®, Basal Insulin, insulin glargine, insulin degludec, insulin detemir, Lantus®, Abasaglar®, Basaglar®, Semglee®, Toujeo®, Tresiba®, Levemir®
Mannkind Corporation, Jaeb Center for Health Research
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/24
04/25
NCT04965051: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Recruiting
N/A
40
RoW
insulin degludec/insulin aspart (IDegAsp), Ryzodeg, basal insulin plus pre-prandial insulin, Levemir/Lantus/Tresiba plus NovoLog/Humalog/Apidra
Second Affiliated Hospital, School of Medicine, Zhejiang University
Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
12/23
12/23

Download Options